Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites

Reovirus is an oncolytic virus (OV), which acts by both direct tumor cell killing and priming of antitumor immunity. A major obstacle for effective oncolytic virotherapy is effective delivery of OV to tumor cells. Ovarian cancer is often confined to the peritoneal cavity and therefore i.p. delivery...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Int J Cancer
Główni autorzy: Jennings, VA, Ilett, EJ, Scott, KJ, West, EJ, Vile, R, Pandha, H, Harrington, K, Young, A, Hall, GD, Coffey, M, Selby, P, Errington-Mais, F, Melcher, AA
Format: Artigo
Język:Inglês
Wydane: BlackWell Publishing Ltd 2014
Hasła przedmiotowe:
Tumor Immunology
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4321045/
https://ncbi.nlm.nih.gov/pubmed/23982804
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.28450
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy